Literature DB >> 21253051

Laboratory Diagnosis of UTI in Family Practice.

D C Brown.   

Abstract

The family physician is in the best position to practise preventive medicine and keep patients healthy by routine urinalysis during each visit. Routine screening of the fresh, meticulously collected mid-stream urine may be done by biochemical screening dipstix, followed up by microscopic examination, where positive for leukocytes, blood, or bacteria. Infections should be cultured in children and recurrent infections in the adult patient. The fresh, properly collected, mid-stream, uncentrifuged urine that has motile bacteria per high-power field is equivalent to a colony count of 100 000 per mL and significant of the urinary tract infection. There is still considerable debate in the literature about the traditional criterion of 100 000 bacteria per mL for urinary tract infection, especially for adults who present with urological symptoms. More long-term research is needed in this area of family practice.

Entities:  

Year:  1988        PMID: 21253051      PMCID: PMC2218772     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  5 in total

1.  Substitution of biochemical urine screening for routine urine microscopy.

Authors:  P Cagle; D Hurst; A Saleem
Journal:  Tex Med       Date:  1986-05

2.  Urine microscopy and infection in general practice.

Authors:  J M Wilks
Journal:  J R Coll Gen Pract       Date:  1979-02

3.  Pyuria: its predictive value of asymptomatic bacteriuria in ambulatory elderly men.

Authors:  D C Norman; R Yamamura; T T Yoshikawa
Journal:  J Urol       Date:  1986-03       Impact factor: 7.450

4.  Urinary tract infection in women visiting rural primary care practices.

Authors:  S Jordan; G M Wilcox; J H Wasson
Journal:  J Fam Pract       Date:  1982-09       Impact factor: 0.493

5.  Causes of the acute urethral syndrome in women.

Authors:  W E Stamm; K F Wagner; R Amsel; E R Alexander; M Turck; G W Counts; K K Holmes
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.